Search results
powder for solution consists of vials of sterile white to off-white powder providing amoxicillin sodium equivalent to 500 mg amoxicillin and potassium clavulanate equivalent to 100 mg clavulanic acid. Each vial contains 1.4 mmoL (31.4 mg) of sodium and 0.5 mmoL (19.6 mg) of potassium.
19 wrz 2023 · Aclav dosage. Oral: Adults and children over 12 years: One 375 mg tablet 3 times a day. In severe infection one 625 mg tablet 3 times a day or one 1 gm tablet two times a day. Children of 6-12 years: 2 teaspoonful Powder for Suspension every 8 hours. Children of 1 -6 years: 1 teaspoonful Powder for Suspension every 8 hours.
2 lut 2023 · Medscape UK - Indication-specific dosage for Co-amoxiclav (amoxicillin and clavulanic acid) oral, precautions and warnings, side effects, pregnancy and lactation, contraindications and full drug monograph.
SUMMARY OF PRODUCT CHARACTERISTICS. 1 NAME OF THE MEDICINAL PRODUCT. Co-Amoxiclav 457mg/5ml Suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION. After reconstitution, each 5ml of oral suspension contains 400 mg amoxicillin (as trihydrate) and 57 mg clavulanic acid (as potassium salt). Excipients with known effect. Aspartame.
Summary of product characteristics, labelling and package leaflet Note: This Summary of Product Characteristics, labelling and package leaflet is the outcome of the referral ... 3 g powder for oral suspension (sachets) Powder for oral suspension White to off -white powder. 250 mg powder for solution for injection or infusion .
ACLAV 1 G / 125 MG, Sachet, pack Boîte de 12, strength 99 , ingredients Amoxicilline - Acide clavulanique, therapeutic classes Antibiotique, pénicilline avec inhibiteur des bêtalactamases, country Morocco.
Aclav 250 mg/125 mg Tablet is a combination of two medicines: Amoxycillin and Clavulanic acid. It is used to treat bacterial infections like, tonsillitis, sinusitis, otitis media, respiratory tract infections, urinary tract infections, boils, abscesses, cellulitis, wound infection, bone infection, and oral cavity infections.
